Terms: = Sarcomas AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
35 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
[TBL] [Abstract] [Full Text] [Related]
3. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
Mochizuki T; Ikegami M; Akiyama T
Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).
Prabaharan CB; Giri S; Allen KJH; Bato KEM; Mercado TR; Malo ME; Carvalho JLC; Dadachova E; Uppalapati M
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570809
[TBL] [Abstract] [Full Text] [Related]
5. Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
Nilsson JN; Siikanen J; Condello V; Jatta K; Saini R; Hedman C; Ihre Lundgren C; Juhlin CC
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37352166
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts.
Yoshuantari N; Jeng YM; Liau JY; Lee CH; Tsai JH
Mod Pathol; 2023 Jan; 36(1):100042. PubMed ID: 36788061
[TBL] [Abstract] [Full Text] [Related]
7. Compound clear cell sarcoma with EWSR1::CREM fusion.
Li P; Busam K
J Cutan Pathol; 2023 Dec; 50(12):1065-1069. PubMed ID: 36640048
[TBL] [Abstract] [Full Text] [Related]
8. Pan-Cancer analysis of tert and Validation in Osteosarcoma Cell Lines.
Xie L; Yin W; Tang F; He M
Biochem Biophys Res Commun; 2023 Jan; 639():106-116. PubMed ID: 36476950
[TBL] [Abstract] [Full Text] [Related]
9. A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Cross W; Lyskjær I; Lesluyes T; Hargreaves S; Strobl AC; Davies C; Waise S; Hames-Fathi S; Oukrif D; Ye H; Amary F; Tirabosco R; Gerrand C; Baker T; Barnes D; Steele C; Alexandrov L; Bond G; ; Cool P; Pillay N; Van Loo P; Flanagan AM
Genome Med; 2022 Aug; 14(1):99. PubMed ID: 36042521
[TBL] [Abstract] [Full Text] [Related]
10. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Nacev BA; Sanchez-Vega F; Smith SA; Antonescu CR; Rosenbaum E; Shi H; Tang C; Socci ND; Rana S; Gularte-Mérida R; Zehir A; Gounder MM; Bowler TG; Luthra A; Jadeja B; Okada A; Strong JA; Stoller J; Chan JE; Chi P; D'Angelo SP; Dickson MA; Kelly CM; Keohan ML; Movva S; Thornton K; Meyers PA; Wexler LH; Slotkin EK; Glade Bender JL; Shukla NN; Hensley ML; Healey JH; La Quaglia MP; Alektiar KM; Crago AM; Yoon SS; Untch BR; Chiang S; Agaram NP; Hameed MR; Berger MF; Solit DB; Schultz N; Ladanyi M; Singer S; Tap WD
Nat Commun; 2022 Jun; 13(1):3405. PubMed ID: 35705560
[TBL] [Abstract] [Full Text] [Related]
11. Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line.
Shi C; Gu Z; Xu S; Ju H; Wu Y; Han Y; Li J; Li C; Wu J; Wang L; Li J; Zhou G; Ye W; Ren G; Zhang Z; Zhou R
Cancer Commun (Lond); 2022 Jul; 42(7):627-647. PubMed ID: 35666052
[TBL] [Abstract] [Full Text] [Related]
12. Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.
Di Noia V; Pimpinelli F; Renna D; Barberi V; Maccallini MT; Gariazzo L; Pontone M; Monti A; Campo F; Taraborelli E; Di Santo M; Petrone F; Mandoj C; Ferraresi V; Ferretti G; Carlini P; Di Bella O; Conti L; La Malfa AM; Pellini R; Bracco D; Giannarelli D; Morrone A; Cognetti F
Clin Cancer Res; 2021 Dec; 27(24):6815-6823. PubMed ID: 34583970
[TBL] [Abstract] [Full Text] [Related]
13. Malignant Sinonasal Tumors: Update on Histological and Clinical Management.
Bracigliano A; Tatangelo F; Perri F; Di Lorenzo G; Tafuto R; Ottaiano A; Clemente O; Barretta ML; Losito NS; Santorsola M; Tafuto S
Curr Oncol; 2021 Jul; 28(4):2420-2438. PubMed ID: 34287240
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
[TBL] [Abstract] [Full Text] [Related]
15. Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and tert promoter mutations: A case report.
Cai JW; Chen XY; Chen JY; Wu ZY; Wu XY; Yu LH; You HH
Medicine (Baltimore); 2021 Apr; 100(13):e25346. PubMed ID: 33787635
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic-prone telomerase reverse transcriptase (tert) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Stenman A; Koman A; Ihre-Lundgren C; Juhlin CC
Medicine (Baltimore); 2021 Jan; 100(2):e24237. PubMed ID: 33466206
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Huang RSP; Haberberger J; Sokol E; Schrock AB; Danziger N; Madison R; Trabucco S; Jin D; Pavlick D; Ramanan V; Hole K; McGregor K; Venstrom J; Ross JS
Int J Cancer; 2021 Apr; 148(7):1778-1788. PubMed ID: 33336398
[TBL] [Abstract] [Full Text] [Related]
18. BRAF mutation, tert promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?
Coskun S; Gamsizkan M; Yilmaz I; Yalcinkaya U; Sungur MA; Buyucek S; Onal B
APMIS; 2020 Sep; 128(9):515-522. PubMed ID: 32580246
[TBL] [Abstract] [Full Text] [Related]
19. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
[TBL] [Abstract] [Full Text] [Related]
20. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
[TBL] [Abstract] [Full Text] [Related]
[Next]
